Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has transformed weight management for millions, with clinical trials showing average weight loss of 15% of body weight over 68 weeks. Many patients wonder whether the standard Wegovy maximum dose of 2.4 mg weekly represents the ceiling for GLP-1 therapy, or if personalized compounded options exist. PlexusDx provides prescription semaglutide injections from licensed 503A compounding pharmacies with dosing flexibility tailored to your individual metabolic response.
What Is the Highest Dose for Wegovy and FDA-Approved Semaglutide?
Wegovy is FDA-approved for chronic weight management at a maximum maintenance dose of 2.4 mg administered once weekly. The manufacturer's titration schedule spans 16 weeks, starting at 0.25 mg and increasing by 0.25 mg every four weeks until reaching the top dose. This standardized approach works well for many patients, but it assumes a one-size-fits-all model that may not align with individual genetic predispositions or metabolic variation.
The 2.4 mg weekly maximum was determined based on efficacy and safety data from the STEP clinical trials, which enrolled thousands of participants across multiple studies. However, these trials included diverse populations with varying degrees of insulin resistance, appetite sensitivity, and genetic factors influencing peptide receptor expression. For some patients, optimal response occurs at 1.5 mg or 2.0 mg, while others may benefit from individualized dosing strategies not limited by fixed FDA-approved endpoints.
Compounded Semaglutide vs. Prescription Wegovy: Key Differences
Prescription Wegovy is manufactured by Novo Nordisk under strict FDA oversight, ensuring consistency and stability through pharmaceutical-grade production. Compounded semaglutide prepared at licensed 503A pharmacies offers an alternative pathway for obtaining semaglutide when prescriber-directed, with flexibility in dosing, formulation, and cost structure that FDA-approved medications cannot provide. While compounded medications are not FDA-approved, they are regulated by state pharmacy boards and must meet United States Pharmacopeia (USP) standards for purity and potency.
PlexusDx partners exclusively with licensed 503A compounding pharmacies—never 503B facilities—ensuring pharmaceutical-grade quality and personalized preparation. This distinction matters: 503A compounders prepare individual prescriptions for specific patients, while 503B facilities operate as manufacturers serving pharmacies and clinics. The 503A model aligns with traditional pharmacy practice and offers greater customization potential for your precise clinical needs.
Personalized Dosing Without Price Escalation
A key principle in PlexusDx's approach is transparent pricing: your dose may go up, but your price won't. Compounded semaglutide injection starts at $149 per month across all commitment tiers, whether your provider prescribes 0.5 mg weekly or a higher individualized dose. This contrasts sharply with retail pharmacy models where dose increases often trigger price jumps, creating financial barriers to reaching therapeutic optimization.
Your provider determines the appropriate starting dose and titration schedule based on your metabolic profile, prior GLP-1 exposure, and clinical goals. Some patients achieve excellent results at lower doses with fewer gastrointestinal side effects, while others require gradual escalation to reach meaningful weight loss. PlexusDx's flat-rate pricing model ensures cost predictability as your treatment evolves, and the service remains available across all 50 states without insurance requirements or membership fees.
The Role of Genetic Testing in Optimizing Your Semaglutide Therapy
PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway genetic assessment that identifies your unique predispositions across 14 biological pathways and 49 peptides. This test examines key variants including GLP1R rs6923761 (GLP-1 receptor sensitivity), GIPR rs1800437 (glucose-dependent insulinotropic peptide responsiveness), FTO rs9939609 (energy homeostasis), and MC4R rs17782313 (appetite regulation). These genetic insights help predict which patients may achieve optimal response at standard doses versus those benefiting from personalized protocols.
Understanding your genetic profile allows your PlexusDx provider to make informed decisions about starting dose, titration pace, and choice of medication—whether semaglutide injection, oral formulations, or combination therapies like GLP-Squared. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of treatment, providing 150+ genetic insights that transform weight loss from trial-and-error into precision medicine. This data-driven approach reduces time spent at suboptimal doses and maximizes your likelihood of sustainable, meaningful weight loss.
Managing Side Effects and Optimizing Tolerability
Gastrointestinal side effects—including nausea, constipation, and vomiting—occur in a subset of GLP-1 patients, particularly during dose escalation phases. Starting at lower doses and titrating gradually allows your body to build tolerance while your provider monitors symptom severity and adjusts the titration schedule. Compounded semaglutide from licensed 503A pharmacies enables precise dose adjustments that may not align with FDA-approved fixed increments, sometimes allowing smaller step increases to minimize tolerability issues.
Beyond dose modification, side effect management includes dietary adjustments (smaller, protein-rich meals), hydration optimization, and physical activity modifications. Some patients benefit from temporary dose holds or slower titration before advancing. PlexusDx providers can coordinate with gastroenterology specialists or other clinicians to ensure holistic management. The goal is finding your therapeutic sweet spot—the dose where weight loss plateaus while side effects remain manageable—rather than blindly pursuing maximum doses.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the highest dose for Wegovy that the FDA approves?
The FDA-approved maximum maintenance dose for Wegovy is 2.4 mg once weekly. However, this represents a standardized endpoint for the clinical trials, not necessarily the optimal dose for every individual patient. PlexusDx works with prescribers to determine personalized dosing based on your specific response patterns.
Can I go above 2.4 mg weekly with compounded semaglutide?
Dosing decisions are made by your prescribing provider based on clinical judgment and your individual needs. Compounded semaglutide from licensed 503A pharmacies offers flexibility that standardized FDA-approved formulations cannot provide, allowing for personalized dosing protocols tailored to your metabolic profile and therapeutic goals.
How much does PlexusDx compounded semaglutide cost?
PlexusDx compounded semaglutide injection starts at $149 per month on the entry tier, with pricing remaining flat regardless of dose adjustments. No insurance is required, and the service is HSA/FSA eligible. This ensures your price stability as your provider optimizes your dose over time.
Are compounded medications as safe as FDA-approved Wegovy?
Compounded medications from licensed 503A pharmacies are regulated by state pharmacy boards and must meet USP standards for purity and potency. While they are not FDA-approved, they follow strict quality protocols. PlexusDx exclusively uses 503A compounders, ensuring pharmaceutical-grade quality and individualized preparation for your specific prescription.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, MC4R, and 10 other genetic pathways to predict your individual peptide responsiveness. This $99 add-on test (available after month one) provides 150+ insights that help your provider select the optimal starting dose and titration strategy, potentially reducing trial-and-error and accelerating your path to therapeutic success.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Understanding When Ozempic® Begins to Work: Your Journey Towards Health
What It Means If Ozempic Isn’t Working For You: Solutions and Next Steps